Solid-Phase Synthesis of Octapeptin Lipopeptides.

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Antimicrobial Research

Background:

• Octapeptins are cyclic lipopeptide antibiotics with demonstrated activity against Gram-negative pathogens.
• Combating antibiotic resistance necessitates novel therapeutic agents, including those targeting resistant strains.

Purpose of the Study:

• To synthesize Octapeptin C4, a representative cyclic lipopeptide antibiotic.
• To establish a robust synthetic route for producing Octapeptin C4 with potential therapeutic applications.

Main Methods:

• Utilized Fmoc solid-phase peptide synthesis (SPPS) on H-L-Leu-2-chlorotrityl resin.
• Employed HCTU/collidine for peptide couplings and N-acylation with 3-(R)-hydroxydecanoic acid.
• Incorporated an orthogonally protected Dab-2 residue (ivDde) for selective deprotection, followed by resin cleavage and solution-phase cyclization using DPPA.

Main Results:

• Successfully synthesized the linear precursor of Octapeptin C4.
• Achieved selective deprotection of the ivDde group.
• Completed the cyclization to yield Octapeptin C4.

Conclusions:

• Demonstrated the feasibility of synthesizing Octapeptin C4 via a combined SPPS and solution-phase cyclization strategy.
• The synthetic route provides a method for generating Octapeptin C4, a potential agent against resistant Gram-negative bacteria.
• This work contributes to the development of new antibiotics to combat antimicrobial resistance.